<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03423693</url>
  </required_header>
  <id_info>
    <org_study_id>Si527/2015</org_study_id>
    <nct_id>NCT03423693</nct_id>
  </id_info>
  <brief_title>Small Airway Obstruction in Asthma, COPD, ACOS</brief_title>
  <official_title>Comparative Study on Sputum Anti-inflammatory Mediators in Patients With Asthma or Asthma and COPD Overlap (ACOS) Syndrome, and COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was designed as retrospective chart review to test our hypothesis whether there
      are the differences in inflammatory and anti-inflammatory mediators between asthmatic and
      ACOS patients with small airway obstruction, and COPD
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The data including spirometry, lung volume, impulse oscillometry, sputum data, demographic
      characters within 6 months are collected for later analysis. Sputum supernatants and
      cytospins are used to determine inflammatory and anti-inflammatory responses in those
      patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lipoxin A4, ,</measure>
    <time_frame>1 day (single time point)</time_frame>
    <description>Lipoxin A4 is measured in sputum supernatants by ELISA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>IL-33</measure>
    <time_frame>1 day (single time point)</time_frame>
    <description>IL-33 is measured in sputum supernatants by ELISA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thymic stromal lymphopoietin (TSLP)</measure>
    <time_frame>1 day (single time point)</time_frame>
    <description>TSLP is measured in sputum supernatants by ELISA</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Asthma</condition>
  <condition>COPD</condition>
  <condition>Asthma-COPD Overlap Syndrome</condition>
  <arm_group>
    <arm_group_label>Asthma with SAO+</arm_group_label>
    <description>Asthmatic patients with RV/TLC &gt; or = 40</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Asthma with SAO-</arm_group_label>
    <description>Asthmatic patients with RV/TLC &lt; 40</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ACO</arm_group_label>
    <description>Asthmatic patients with smoking &gt; or = 10 pack years who have persistent airway obstruction (post-BD FEV1/FVC &lt; 0.7) or COPD patients who have bronchodilator (BD) reversibility (absolute increase in FEV1 &gt; or = 200 ml and FEV1% &gt; or =12% after BD)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COPD</arm_group_label>
    <description>Patients with history of smoking &gt; or = 10 pack year with post-BD FEV1/FVC &lt; 0.7 and negative BD reversibility (absolute increase in FEV1 &lt; 200 ml and FEV1% &lt;12% after BD)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No any intervention</intervention_name>
    <description>No any intervention is applied to any groups in this study</description>
    <arm_group_label>Asthma with SAO+</arm_group_label>
    <arm_group_label>Asthma with SAO-</arm_group_label>
    <arm_group_label>ACO</arm_group_label>
    <arm_group_label>COPD</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Sputum cell pellets, sputum supernatants, and sputum cytospins
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants recruited from Asthma Clinics and OPD in Siriraj Hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Physician-diagnosed asthma, ACO, and COPD

          -  Their spirometric, IOS, lung volume, demographic data and sputum samples are available

        Exclusion Criteria:

          -  Concomitant diseases requiring immunosuppressive therapy

          -  Being on treatments with NSAIDs, macrolides, statins
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kittipong Maneechotesuwan, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine Siriraj Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kittipong Maneechotesuwan, MD, PhD</last_name>
    <phone>6624197757</phone>
    <email>kittipong.man@mahidol.ac.th</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jirawatana Ahussawabhumi, BSc</last_name>
    <phone>6624197757</phone>
    <phone_ext>24</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Siriraj Hospital</name>
      <address>
        <city>Bangkok Noi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jirawatana Ahussawabhumi, BSc.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2018</study_first_submitted>
  <study_first_submitted_qc>February 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2018</study_first_posted>
  <last_update_submitted>February 5, 2018</last_update_submitted>
  <last_update_submitted_qc>February 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Kittipong Maneechotesuwan</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Small airway obstruction</keyword>
  <keyword>Asthma</keyword>
  <keyword>COPD</keyword>
  <keyword>ACOS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Airway Obstruction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

